Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,619 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries.
Vitale A, Palacios-Olid J, Caggiano V, Ragab G, Hernández-Rodríguez J, Pelegrín L, Mejía-Salgado G, Zarate-Pinzón L, Gentileschi S, Sota J, Fonollosa A, Carreño E, Gaggiano C, Amin RH, Balistreri A, Narváez J, Tosi GM, Frediani B, Cantarini L, de-la-Torre A, Fabiani C. Vitale A, et al. Among authors: de la torre a. Front Med (Lausanne). 2024 Aug 23;11:1439338. doi: 10.3389/fmed.2024.1439338. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39247640 Free PMC article.
Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium.
Cao Z, Wong F, Choudhury AK, Kamath PS, Topazian M, Torre A, Hayes PC, George J, Idilman R, Seto WK, Desalegn H, Alvares-da-Silva MR, Bush BJ, Thacker LR, Xie Q, Bajaj JS; CLEARED Consortium. Cao Z, et al. Among authors: torre a. Lancet Gastroenterol Hepatol. 2024 Sep 4:S2468-1253(24)00224-3. doi: 10.1016/S2468-1253(24)00224-3. Online ahead of print. Lancet Gastroenterol Hepatol. 2024. PMID: 39243795
Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity.
Moreno-Arciniegas A, García A, Kelm M, D'Amore F, da Silva MG, Sánchez-González J, Sánchez PL, López-Fernández T, Córdoba R, Asteggiano R, Camus V, Smink J, Ferreira A, Kersten MJ, Bolaños N, Escalera N, Pacella E, Gómez-Talavera S, Quesada A, Rosselló X, Ibanez B; RESILIENCE Trial Investigators. Moreno-Arciniegas A, et al. Eur J Heart Fail. 2024 Aug 30. doi: 10.1002/ejhf.3395. Online ahead of print. Eur J Heart Fail. 2024. PMID: 39212445
1,619 results